Infugem™ (gemcitabine) – New drug approval
July 18, 2018 - Sun Pharma announced the FDA approval of Infugem (gemcitabine), for the treatment of advanced ovarian cancer; metastatic breast cancer; inoperable, locally advanced, or metastatic non-small cell lung cancer; and locally advanced or metastatic adenocarcinoma of the pancreas.
Top